Windtree Therapeutics, Inc.
WINT
$0.8522
$0.00330.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -10.38% | -11.68% | -14.36% | -10.26% | -14.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.41% | 62.15% | 67.10% | 6.96% | -17.78% |
| Operating Income | -41.41% | -62.15% | -67.10% | -6.96% | 17.78% |
| Income Before Tax | 91.16% | 63.21% | 57.13% | 84.01% | 49.99% |
| Income Tax Expenses | -- | 105.19% | 122.75% | 108.34% | -- |
| Earnings from Continuing Operations | 91.19% | 60.90% | 53.46% | 83.06% | 48.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 91.19% | 60.90% | 53.46% | 83.06% | 48.25% |
| EBIT | -41.41% | -62.15% | -67.10% | -6.96% | 17.78% |
| EBITDA | -41.08% | -61.91% | -67.18% | -7.06% | 17.65% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |